CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.

Oncology
Reviewed By
Dr Gemma Eminowicz MBChB, MRCP, FRCR, MD(Res) is a Consultant Clinical Oncologist and Brachytherapy lead treating Gynaecological cancers at University College London Hospital (UCLH). She is also an honorary clinical associate professor at University College London (UCL), chair of the GEC-ESTRO gynae working group, member of ESTRO gynae focus group, organiser of gyn-SMART webinars and principle investigator on many systemic therapy clinical trials including at a UK level (eg Keynote B21).
She has published 26 oncology papers, 8 as first author and multiple book chapters. She has been heavily involved in the practice changing INTERLACE trial from radiotherapy quality assurance to analysis of final results and dissemination of primary and secondary outcome data. She remains active with in ESTRO, ESGO, BGCS and GTG-UK and strives to improve patient care through multidisciplinary treatments focusing on systemic therapy and high quality radiotherapy.
Treatments:
Treats:
Clinical Oncology
English
MBChB MRCP, FRCR MD(Res)
General Medical Council: 6099426
5th Floor UCH Macmillan Cancer Centre, Huntley Street, London, WC1E 6AG
Unavailable
New appointment: £360
Follow-up appointment: £200
Reviewed By